Drug Shortage Report for APO-SERTRALINE

Last updated on 2020-03-09 History
Report ID 85613
Drug Identification Number 02238281
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SERTRALINE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 250 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-03
Estimated end date 2020-03-06
Actual end date 2020-03-05
Shortage status Resolved
Updated date 2020-03-09
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-03-09 French Compare
v14 2020-03-09 English Compare
v13 2020-02-21 French Compare
v12 2020-02-21 English Compare
v11 2019-12-19 French Compare
v10 2019-12-19 English Compare
v9 2019-10-18 French Compare
v8 2019-10-18 English Compare
v7 2019-06-25 French Compare
v6 2019-06-25 English Compare
v5 2019-06-05 French Compare
v4 2019-06-05 English Compare
v3 2019-06-05 French Compare
v2 2019-06-05 English Compare
v1 2019-06-05 English Compare